Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 14, 2026 10:08 ET | Source: Research and Markets

$22.92 Bn Tiny Machine Learning Market, 2040

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Tiny Machine Learning Market, Till 2040: Distribution by Component, Deployment Mode, Type of Language, Application, End User, Geographical Regions, and...
May 14, 2026 10:05 ET | Source: Research and Markets

Japan $2.62 Bn Point-of-care Diagnostics Market Trends and Forecasts 2026-2035: Focus on Preventive Care Offering Opportunities in Chronic Disease Management and Digital Health Integration

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Japan Point-of-care Diagnostics Market - Distribution by Target Disease Indication and Type of Technology: Industry Trends and Forecasts, till 2035" has...
May 14, 2026 10:05 ET | Source: StarRez

StarRez Report: Students Want More Help from Institutions When They Move Off-Campus

GREENWOOD VILLAGE, Colo., May 14, 2026 (GLOBE NEWSWIRE) -- StarRez, a global leader in on- and off-campus student housing software, and its celebrated off-campus housing solution, CollegePads, today...
May 14, 2026 10:00 ET | Source: Aqua-Tots Swim Schools

Aqua-Tots Swim School Expands in Canada with New Ajax Location

Phoenix, AZ, May 14, 2026 (GLOBE NEWSWIRE) -- Aqua-Tots Swim School, the world’s largest swim school franchise, announced the opening of its newest location in Ajax, Ontario. As the seventh...
May 14, 2026 09:50 ET | Source: Schall Law

LU Investors Have Opportunity to Lead Lufax Holding Ltd Securities Fraud Lawsuit with the Schall Law Firm

LU Investors Have Opportunity to Lead Lufax Holding Ltd Securities Fraud Lawsuit with the Schall Law Firm
May 14, 2026 09:45 ET | Source: Research and Markets

CD47 and SIRP-alpha Targeted Immunotherapy Pipeline Competitor Analysis Report 2026: Active R&D Programs by R&D Phase and Profile of Inhibitors by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of CD47 and SIRP-alpha Targeted Immunotherapy" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report...
May 14, 2026 09:44 ET | Source: Research and Markets

Claudin 18.2-Targeted Immunotherapy Pipeline Competitor Analysis Report 2026: Active R&D Programs by R&D Phase and Profile of Inhibitors by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of Claudin 18.2-Targeted Immunotherapy" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
May 14, 2026 09:43 ET | Source: Research and Markets

Complement C5 Inhibitors & C5 Receptor Antagonists Pipeline Competitor Analysis Report 2026: Active R&D Programs by R&D Phase and Profile of Targeted Immunotherapies by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of Complement C5 Inhibitors & C5 Receptor Antagonists" report has been added to ResearchAndMarkets.com's offering.This competitive...
May 14, 2026 09:42 ET | Source: Research and Markets

NaPi2b-Targeted Immunotherapies Pipeline Competitor Analysis Report 2026: Active R&D Programs by R&D Phase and Profile of Targeted Immunotherapies by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of NaPi2b-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...
May 14, 2026 09:41 ET | Source: Research and Markets

KLK2-Targeted Immunotherapies Pipeline Competitor Analysis Report 2026: Active R&D Programs by R&D Phase and Profile of Targeted Immunotherapies by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Pipeline of KLK2-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report about...